Brookline Capital Markets Downgrades Fusion Pharmaceuticals (FUSN) to Hold

March 19, 2024 10:28 AM

Brookline Capital Markets analyst Kemp Dolliver downgraded Fusion Pharmaceuticals ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found